☆ 4.6 Letter

Rhabdomyolysis After Low-Dose Quetiapine in a Patient with Parkinson's Disease with Drug-Induced Psychosis: A Case Report

MOVEMENT DISORDERS (2010)

期刊

MOVEMENT DISORDERS

卷 25, 期 6, 页码 790-791

出版社

WILEY

DOI: 10.1002/mds.23015

关键词

类别

Clinical Neurology

向作者/读者索取更多资源

Protocol

社区支持

Reagent

社区支持

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

主要评分

4.6

评分不足

次要评分

新颖性

重要性

科学严谨性

评价这篇论文

Association of Low-Dose Quetiapine and Diabetes

Mikkel Hojlund, Lars C. Lund, Kjeld Andersen, Christoph U. Correll, Jesper Hallas

Summary: The use of low-dose quetiapine was not found to be significantly associated with an increased risk of type 2 diabetes compared to SSRIs in this cohort study.

JAMA NETWORK OPEN (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Case Report: Etoposide-nedaplatin induced rhabdomyolysis in a small cell lung cancer patient

Xiaohu Xu, Xiao Wu, Mingmin Zhang, Qi Wang

Summary: This article describes the first case of severe rhabdomyolysis induced by etoposide-nedaplatin chemotherapy in a patient with small cell lung cancer. The patient experienced progressive muscle pain and weakness after the first cycle of chemotherapy. The diagnosis of severe chemotherapy-induced rhabdomyolysis was made after excluding other causes and the patient showed improvement after treatment.

FRONTIERS IN PHARMACOLOGY (2023)

添加到收藏夹

Article Oncology

Rhabdomyolysis in a patient with advanced lung cancer treated with osimertinib: a case report

You Li, Yu Liu, Zichen Zhao, Yan Zhang

Summary: This case report presents a lung adenocarcinoma patient who developed osimertinib-associated rhabdomyolysis (RM) during treatment. Osimertinib-associated RM is a rare complication, but it requires clinical attention, especially in patients receiving osimertinib plus bevacizumab. Timely withdrawal of osimertinib and laboratory tests for creatine kinase and myoglobin levels are necessary to identify the cause.

TRANSLATIONAL LUNG CANCER RESEARCH (2023)

添加到收藏夹

Article Medicine, General & Internal

Low-dose topiramate and hydrochlorothiazide-associated early acute myopia and angle narrowing: A case report

Chao Wu, Hong Pan, Shijun Feng, Xiaokun Wang, Zhaoqiang Liu, Bojun Zhao

Summary: A 34-year-old Asian woman experienced acute bilateral myopia and angle narrowing 6 hours after taking one dose of topiramate, hydrochlorothiazide, and fluoxetine to lose weight. With the discontinuation of the drugs and the use of IOP-lowering medication, the patient fully recovered.

FRONTIERS IN MEDICINE (2023)

添加到收藏夹

Article Neurosciences

Acute Visual Impairment in a Patient with Parkinson's Disease after Successful Bilateral Subthalamic Nucleus Deep Brain Stimulation with Low-Dose Levodopa: A Case Report

Chao Zhang, Jinxing Sun, Zhenke Li, Na Liu, Chao Li

Summary: In this case report, a patient with Parkinson's disease who underwent STN-DBS experienced visual symptoms that were resolved by adjusting the levodopa dosage. The results suggest that STN-DBS can improve eye-blink rate in patients with Parkinson's disease, but rapid reduction of levodopa dosage after STN-DBS may lead to retinal atrophy and decreased vessel density in the ocular fundus.

BRAIN SCIENCES (2023)

添加到收藏夹

Article Pediatrics

Case Report: Atypical HUS Presenting With Acute Rhabdomyolysis Highlights the Need for Individualized Eculizumab Dosing

Stefanie W. Benoit, Tsuyoshi Fukuda, Katherine Vanden Heuvel, David Witte, Christine Fuller, Jennifer Willis, Bradley P. Dixon, Keri A. Drake

Summary: This report demonstrates the case of a 4-year-old male who suffered from rhabdomyolysis preceding the development of aHUS. The patient required increased and more frequent doses of eculizumab for clinical stabilization. Pharmacokinetic analysis indicated that individualized dosing every 3 weeks could maintain adequate eculizumab levels. Cost analyses showed that this dosing regimen would result in significant cost savings compared to standard weight-based dosing.

FRONTIERS IN PEDIATRICS (2022)

添加到收藏夹

Article Infectious Diseases

Fatal thrombotic microangiopathy with rhabdomyolysis as an initial symptom after the first dose of mRNA-1273 vaccine: A case report

Yuya Kamura, Toshiki Terao, Satoshi Akao, Yumi Kono, Koichi Honma, Kosei Matsue

Summary: We report a case of a Japanese man who developed severe rhabdomyolysis and multiple thrombosis of arterioles after receiving the mRNA-1273 vaccine. Despite intensive treatment, the patient ultimately died of multiple organ failure. Autopsy findings suggest a possible immune-mediated mechanism.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Psychiatry

Associations between off-label low-dose olanzapine or quetiapine and cardiometabolic mortality

Jonas Berge, Paul Abri, Pontus Andell, Pouya Movahed, Dragos C. Ragazan

Summary: The study found that low-dose olanzapine/quetiapine treatment is weakly associated with cardiometabolic mortality, with short-term treatment potentially reducing the risk but long-term treatment increasing the risk.

JOURNAL OF PSYCHIATRIC RESEARCH (2022)

添加到收藏夹

Article Medicine, General & Internal

Low-dose atorvastatin therapy induced rhabdomyolysis in a liver cirrhosis patient - a case report

Shashank Bhattarai, Sandip Pradhan, Shraddha Bhattarai

Summary: This case report highlights the risk of statin-induced muscle injury, specifically rhabdomyolysis, in patients with chronic liver disease. Atorvastatin, a commonly prescribed statin, was found to be the causative agent for muscle tenderness and decreased muscle power in this patient with liver cirrhosis.

ANNALS OF MEDICINE AND SURGERY (2023)

添加到收藏夹

Article Environmental Sciences

Overdose of Quetiapine-A Case Report with QT Prolongation

Elisabetta Bertol, Fabio Vaiano, Antonina Argo, Stefania Zerbo, Claudia Trignano, Simone Protani, Donata Favretto

Summary: Quetiapine is a medication used to treat various mental disorders, but overdose can be life-threatening. A case study of a 75-year-old male who attempted suicide by ingesting a large amount of Quetiapine without other medications was presented, and a complete pharmacokinetic analysis was conducted during his management in the emergency department.

TOXICS (2021)

添加到收藏夹

Article Medicine, General & Internal

Omeprazole was safely reused in a rhabdomyolysis patient associated with proton pump inhibitors: A case report

Zhen Wang, Jun Shen, Lei Zhang

Summary: Proton pump inhibitors (PPIs) are commonly used in the treatment of abnormal gastric acid secretion and gastric acid related diseases. This case report highlights the management and resolution of PPIs-induced rhabdomyolysis through medication alteration and blood purification therapy.

CLINICAL CASE REPORTS (2023)

添加到收藏夹

Article Medicine, General & Internal

Case report: Successful outcome of a young patient with rhabdomyolysis and shock caused by diquat poisoning

Yunchao Chen, Zejin Ou, Ruichang Zhang, Zhenhong Long, Rushen Fu, Shihao Tang, Zhi Wang

Summary: This is the first successful case of diquat poisoning complicated with rhabdomyolysis and shock, which will enrich the experience of diquat poisoning treatment.

FRONTIERS IN MEDICINE (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

Case report: Supratherapeutic tacrolimus concentrations with nirmatrelvir/ritonavir in a lung transplant patient: a case report using Rifampin for reversal

Yu Xiong, Xiaoxing Wang, Shu Li, Qian Zhang, Lijuan Guo, Wenhui Chen, Zhixia Zhao, Lihong Liu

Summary: This case report highlights a drug interaction in a lung transplant patient who self-administered Paxlovid for COVID-19 without discontinuing tacrolimus. The patient experienced tacrolimus toxicity due to the elevated plasma concentration caused by the interaction. Urgent medical intervention and dosage adjustment effectively managed the situation. Medication education for transplant patients is crucial in preventing such interactions.

FRONTIERS IN PHARMACOLOGY (2023)

添加到收藏夹

Article Medicine, General & Internal

Psychosis in a primary hyperparathyroidism patient with mild hypercalcemia A case report

Koji Otsuki, Muneto Izuhara, Shoko Miura, Satoko Yamashita, Michiharu Nagahama, Maiko Hayashida, Sadayuki Hashioka, Tsuyoshi Miyaoka, Yukie Hotta, Yasuhiko Shimizu, Masatoshi Inagaki

Summary: PHPT can present with various severe psychiatric symptoms, even in cases of mild hypercalcemia. Psychiatric symptoms may be the only prominent symptoms in PHPT, and clinicians should suspect PHPT in patients with psychiatric symptoms and mild hypercalcemia. Furthermore, PTX is recommended for PHPT-even in the presence of severe uncontrolled psychiatric symptoms, as psychiatric symptoms are likely to improve and good postoperative management is possible.

MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Case report: Rhabdomyolysis and kidney injury in a statin-treated hypothyroid patient-kill two birds with one stone

Wen-Fang Chiang, Jenq-Shyong Chan, Po-Jen Hsiao, Shih-Hua Lin

Summary: Statin treatment for hypercholesterolemia can cause reversible rhabdomyolysis and acute kidney injury. This case highlights the importance of considering hypothyroidism, which can present with concomitant myopathy and kidney injury, in patients with persistent symptoms after discontinuation of statin therapy.

FRONTIERS IN MEDICINE (2022)

添加到收藏夹

Letter Clinical Neurology

Intravenous iron supplementation therapy Restless-Legs-Syndrome

Michael Bartl, Claudia Trenkwalder, Maria-Lucia Muntean, Friederike Sixel-Doering

NERVENARZT (2021)

添加到收藏夹

Article Clinical Neurology

Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study

Regina Katzenschlager, Werner Poewe, Olivier Rascol, Claudia Trenkwalder, Guenther Deuschl, K. Ray Chaudhuri, Tove Henriksen, Teus van Laar, Donna Lockhart, Harry Staines, Andrew Lees

Summary: The TOLEDO study showed that apomorphine infusion is an effective and safe treatment for reducing motor fluctuations in Parkinson's disease patients. Long-term use of APO led to sustained reductions in OFF time and improvements in ON time without troublesome dyskinesia, allowing for significant decreases in oral PD medication.

PARKINSONISM & RELATED DISORDERS (2021)

添加到收藏夹

Article Clinical Neurology

Clinically relevant copy-number variants in exome sequencing data of patients with dystonia

Michael Zech, Sylvia Boesch, Matej Skorvanek, Jan Necpal, Jana Svantnerova, Matias Wagner, Yasemin Dincer, Ariane Sadr-Nabavi, Teresa Serranova, Irena Rektorova, Petra Havrankova, Shahzaman Ganai, Alexandra Mosejova, Iva Prihodova, Jana Sarlakova, Kristina Kulcsarova, Olga Ulmanova, Karel Bechyne, Miriam Ostrozovicova, Vladimir Han, Joaquim Ribeiro Ventosa, Mohammad Shariati, Ali Shoeibi, Sandrina Weber, Brit Mollenhauer, Claudia Trenkwalder, Riccardo Berutti, Tim M. Strom, Andres Ceballos-Baumann, Volker Mall, Bernhard Haslinger, Robert Jech, Juliane Winkelmann

Summary: Utilizing whole-exome sequencing data for CNV analysis can increase the diagnostic yield for dystonia. Prioritizing rare CNVs that affect known disease genes or are associated with specific microdeletion/microduplication syndromes based on a well-established assessment standard. The study identified pathogenic CNVs in a small percentage of patients, highlighting the importance of combining CNV analysis with the assessment of single-nucleotide variants and small insertions/deletions for improved genetic diagnosis in dystonia.

PARKINSONISM & RELATED DISORDERS (2021)

添加到收藏夹

Editorial Material Neurosciences

COVID-19 Vaccination for Persons with Parkinson's Disease: Light at the End of the Tunnel?

Bastiaan R. Bloem, Claudia Trenkwalder, Alvaro Sanchez-Ferro, Lorraine V. Kalia, Roy Alcalay, Han-Lin Chiang, Un Jung Kang, Christopher Goetz, Patrik Brundin, Stella M. Papa

Summary: Despite concerns raised by people with Parkinson's disease (PD) and their physicians regarding the efficacy and safety of COVID-19 vaccines in the specific context of PD and its treatment, current literature and experience with widespread vaccination suggest that COVID-19 vaccination with approved vaccines is recommended for PD patients, unless there is a specific contraindication.

JOURNAL OF PARKINSONS DISEASE (2021)

添加到收藏夹

Article Clinical Neurology

Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders

Isabel Schulz, Niels Kruse, Roland G. Gera, Thomas Kremer, Jesse Cedarbaum, Robin Barbour, Wagner Zago, Sebastian Schade, Birgit Otte, Michael Bartl, Samantha J. Hutten, Claudia Trenkwalder, Brit Mollenhauer

Summary: Objective diagnostic biomarkers are needed to support a clinical diagnosis of neurodegenerative disorders, with various markers being analyzed in serum and/or cerebrospinal fluid for alpha-synuclein-related disorders. Levels of most markers tested significantly differed between disease groups and healthy controls, with CSF NfL levels best discriminating between Parkinson's disease and multiple system atrophy.

MOVEMENT DISORDERS (2021)

添加到收藏夹

Article Clinical Neurology

Blood DNA methylation provides an accurate biomarker of KMT2B-related dystonia and predicts onset

Nazanin Mirza-Schreiber, Michael Zech, Rory Wilson, Theresa Brunet, Matias Wagner, Robert Jech, Sylvia Boesch, Matej Skorvanek, Jan Necpal, David Weise, Sandrina Weber, Brit Mollenhauer, Claudia Trenkwalder, Esther M. Maier, Ingo Borggraefe, Katharina Vill, Annette Hackenberg, Veronika Pilshofer, Urania Kotzaeridou, Eva Maria Christina Schwaibold, Julia Hoefele, Melanie Waldenberger, Christian Gieger, Annette Peters, Thomas Meitinger, Barbara Schormair, Juliane Winkelmann, Konrad Oexle

Summary: This study reports a biomarker for KMT2B-deficient dystonia, which can accurately identify the deficiency and predict the severity and onset age of the disease by analyzing 113 DNA CpG sites.

BRAIN (2022)

添加到收藏夹

Article Clinical Neurology

Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies

Ilaria Poggiolini, Vandana Gupta, Michael Lawton, Seoyun Lee, Aadil El-Turabi, Agustin Querejeta-Coma, Claudia Trenkwalder, Friederike Sixel-Doering, Alexandra Foubert-Samier, Anne Pavy-Le Traon, Giuseppe Plazzi, Francesco Biscarini, Jacques Montplaisir, Jean-Francois Gagnon, Ronald B. Postuma, Elena Antelmi, Wassilios G. Meissner, Brit Mollenhauer, Yoav Ben-Shlomo, Michele T. Hu, Laura Parkkinen

Summary: The study aimed to assess the diagnostic value of CSF alpha-synuclein RT-QuIC quantitative parameters in regard to disease progression, stratification, and conversion in synucleinopathies. The results showed that alpha-synuclein RT-QuIC adds value in diagnosing Parkinson's disease and may provide a way to distinguish variations within Parkinson's disease phenotype. The assay also showed potential as an early biomarker detecting synucleinopathy in idiopathic REM sleep behaviour disorder patients prior to conversion.

BRAIN (2022)

添加到收藏夹

Article Psychology, Clinical

Dynamic Interplay of Cognitive Functioning and Depressive Symptoms in Patients With Parkinson's Disease

Ulrich Schroeders, Johannes Zimmermann, Tamara Wicke, Martina Schaumburg, Elisabeth Lang, Claudia Trenkwalder, Brit Mollenhauer

Summary: This study examines the trajectories and dynamic interplay between cognitive functioning and depressive symptoms in patients with Parkinson's disease (PD) compared to healthy controls (HC) from an intraindividual perspective. The results indicate that PD patients have worse cognitive abilities compared to HC, and greater impairments in cognitive abilities are subsequently associated with increased depressive symptoms.

NEUROPSYCHOLOGY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Early downregulation of hsa-miR-144-3p in serum from drug-naive Parkinson's disease patients

Elisa Zago, Alessandra Dal Molin, Giovanna Maria Dimitri, Luciano Xumerle, Chiara Pirazzini, Maria Giulia Bacalini, Maria Giovanna Maturo, Tiago Azevedo, Simeon Spasov, Pilar Gomez-Garre, Maria Teresa Perinan, Silvia Jesus, Luca Baldelli, Luisa Sambati, Giovanna Calandra-Buonaura, Paolo Garagnani, Federica Provini, Pietro Cortelli, Pablo Mir, Claudia Trenkwalder, Brit Mollenhauer, Claudio Franceschi, Pietro Lio, Christine Nardini

Summary: This study aims to investigate the relevance of microRNAs as biomarkers of Parkinson's Disease within the ageing framework. The down-regulation of hsa-miR-144-3p in early Parkinson's Disease patients and its involvement in the regulation of coagulation were consistently observed.

SCIENTIFIC REPORTS (2022)

添加到收藏夹

Article Neurosciences

Long-Term Cognitive Decline Related to the Motor Phenotype in Parkinson's Disease

Jennifer Michels, Hendrick van der Wurp, Elke Kalbe, Sarah Petra Rehberg, Alexander Storch, Katharina Linse, Christine Schneider, Susanne Graeber, Daniela Berg, Judith Dams, Monika Balzer-Geldsetzer, Ruediger Hilker-Roggendorf, Carola Oberschmidt, Simon Baudrexel, Karsten Witt, Nele Schmidt, Gunther Deuschl, Brit Mollenhauer, Claudia Trenkwalder, Inga Liepelt-Scarfone, Annika Spottke, Sandra Roeske, Ullrich Wuellner, Hans-Ulrich Wittchen, Oliver Riedel, Jan Kassubek, Richard Dodel, Joerg Bernhard Schulz, Ana Sofia Costa, Kathrin Reetz

Summary: The study found that motor symptoms increased as the disease progressed in all PD subgroups. After a three-year follow-up, PIGD patients showed a significant decline in overall cognitive performance, with differences in attention and memory functions compared to the ND group. This suggests distinct neuropsychological progression patterns in different PD motor phenotypes, with PIGD patients showing a greater risk of dementia over time.

JOURNAL OF PARKINSONS DISEASE (2022)

添加到收藏夹

Article Neurosciences

Longitudinal Change and Progression Indicators Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale in Two Independent Cohorts with Early Parkinson's Disease

Michael Bartl, Mohammed Dakna, Sebastian Schade, Tamara Wicke, Elisabeth Lang, Jens Ebentheuer, Sandrina Weber, Claudia Trenkwalder, Brit Mollenhauer

Summary: A systematic analysis of single items within the MDS-UPDRS scale revealed that higher scores for ADL, freezing, and rigidity at baseline were predictive of faster disease progression in both cohorts. Precision and predictability of the MDS-UPDRS were higher in single-center settings, highlighting the need for rigorous training and/or video documentation to improve its utility in multi-center cohorts, such as clinical trials.

JOURNAL OF PARKINSONS DISEASE (2022)

添加到收藏夹

Article Neurosciences

Rare PSAP Variants and Possible Interaction with GBA in REM Sleep Behavior Disorder

Yuri L. Sosero, Eric Yu, Mehrdad A. Estiar, Lynne Krohn, Kheireddin Mufti, Uladzislau Rudakou, Jennifer A. Ruskey, Farnaz Asayesh, Sandra B. Laurent, Dan Spiegelman, Jean-Francois Trempe, Timothy G. Quinnell, Nicholas Oscroft, Isabelle Arnulf, Jacques Y. Montplaisir, Jean-Francois Gagnon, Alex Desautels, Yves Dauvilliers, Gian Luigi Gigli, Mariarosaria Valente, Francesco Janes, Andrea Bernardini, Karel Sonka, David Kemlink, Wolfgang Oertel, Annette Janzen, Giuseppe Plazzi, Elena Antelmi, Francesco Biscarini, Michela Figorilli, Monica Puligheddu, Brit Mollenhauer, Claudia Trenkwalder, Friederike Sixel-Doering, Valerie Cochen De Cock, Christelle Charley Monaca, Anna Heidbreder, Luigi Ferini-Strambi, Femke Dijkstra, Mineke Viaene, Beatriz Abril, Bradley F. Boeve, Ronald B. Postuma, Guy A. Rouleau, Abubaker Ibrahim, Ambra Stefani, Birgit Hogl, Michele T. M. Hu, Ziv Gan-Or

Summary: This study found that loss-of-function mutations in the PSAP gene were present in patients with iRBD, and the co-occurrence with GBA variants suggests a potential genetic interaction. These findings may have implications for understanding the prodromal stage of synucleinopathy and the development of Parkinson's disease.

JOURNAL OF PARKINSONS DISEASE (2022)

添加到收藏夹

Article Neurosciences

Metabolite and lipoprotein profiles reveal sex-related oxidative stress imbalance in de novo drug-naive Parkinson's disease patients

Gaia Meoni, Leonardo Tenori, Sebastian Schade, Cristina Licari, Chiara Pirazzini, Maria Giulia Bacalini, Paolo Garagnani, Paola Turano, Claudia Trenkwalder, Claudio Franceschi, Brit Mollenhauer, Claudio Luchinat

Summary: Parkinson's disease is the neurological disorder with the highest increase in prevalence. The lack of precise diagnosis at early stages remains a challenge. Metabolomics has provided valuable insights into the molecular basis of PD and potential biomarkers for early detection and treatment efficacy. In this study, NMR was used to analyze serum samples from German PD patients, revealing more pronounced pathological characteristics in male patients and confirming altered levels of acetone and cholesterol. Additionally, stronger oxidative stress markers were detected.

NPJ PARKINSONS DISEASE (2022)

添加到收藏夹

Meeting Abstract Clinical Neurology

REM Sleep Behaviour Disorder (RBD): future implications for neurodegenerative disease

C. Trenkwalder

EUROPEAN JOURNAL OF NEUROLOGY (2021)

添加到收藏夹

Meeting Abstract Clinical Neurology

Opicapone OASIS study in Parkinson's: design of an open-label, single-arm, pilot trial

R. Costa, C. Trenkwalder, J. Ferreira, D. Magalhaes, J. Rocha, P. Soares-da-Silva

EUROPEAN JOURNAL OF NEUROLOGY (2021)

添加到收藏夹

暂无数据

Rhabdomyolysis After Low-Dose Quetiapine in a Patient with Parkinson's Disease with Drug-Induced Psychosis: A Case Report

期刊

出版社

WILEY

关键词

类别

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

评论

主要评分

次要评分

新颖性

重要性

科学严谨性

评价这篇论文

推荐

导出引文

分享论文